Novartis 'biosimilar' drug blocked by U.S. appeals court

(Reuters) - A U.S. appeals court has blocked the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, the blockbuster Amgen Inc drug used to prevent infections in cancer patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news